Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 143 of 144 pages ‹ First < 141 142 143 144 >
HSL1854
Candy PC.
Preventing "information overdose": developing information-literate practitioners.
J Contin Educ Health Prof 2000 Fal; 20:(4):228-37
HSL2038
Braithwaite J, Drahos P.
Global business regulation.
Cambridge: Cambridge University Press 2000
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521784999
HSL2054
Sutherland M, Sylvester AK.
Advertising and the Mind of the Consumer 2nd Ed: What works, what doesn't, and why.
Sydney: Allen & Unwin 2000
http://www.allen-unwin.com.au/Shopping/SearchResults.aspx?search=Advertising+and+the+Mind+of+the+Consumer+
HSL2242
Roughead L, Semple S, Vitry A.
The Value of Pharmacist Professional Services in the Community: A systematic review of the literature 1990-2002
2000
HSL2317
Freemantle , N. JOHNSSON, R. , Dennis J., Kennedy , A. MARCHMENT, M
Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/ industry intervention to influence prescribing practice.
British Journal of Clinical Pharmacology 2000; 49:174-179
HSL2581
Sweet M.
Medicines and the media: a journalist's view
Australian Prescriber 2000; 23:(4):70-1
http://www.australianprescriber.com
HSL2592
Roughead L, Gilbert A.
Medicines and the media
Australian Prescriber 2000; 23:(6):115
http://www.australianprescriber.com
HSL2625
Morgan S, Barer M, Evans R.
Buying science, selling drugs
Health Matters 2000; 43:12-13
HSL3696
Slaughter E, Schumacher M.
Prevention’s international survey on wellness and consumer reactions to DTC Advertising of Rx drugs
Prev Mag 2000;
HSL5343
Kohn LT, Corrigan JM, Donaldson MS, .
To Err Is Human: Building a Safer Health System
Washington, DC: National Academies Press 2000
HSL5426
Baron J.
Thinking and Deciding 3rd edn
Cambridge: Cambridge University Press 2000
HSL6205
Sparrow MK.
The regulatory craft: Controlling risks, solving problems and managing compliance
Washington: The Brookings Institution 2000
HSL6920
Ala-fossi N, Vilhunen S, Lilja J, Enlund H.
Promoting antidepressants to physicians in Finnish direct mail and journal advertisements
Journal of Social and Administrative Pharmacy 2000; 17:9-14
HSL6921
Day R.
How to make the most of a visit from a pharmaceutical company representative
Australian Prescriber 2000; 23:(5):97-99
http://www.australianprescriber.com
HSL6922
Dennis RJ.
Drug promotion: Does the right hand know what the left is doing?
Pharmacoepidemiology and Drug Safety 2000; 9:291-292
HSL6923
Kopp SW, Bang HK.
Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications
Health Mark Q 2000; 17:(3):39-56
HSL6924
Lexchin J.
Double standards: Double jeopardy
Pharmacoepidemiology and Drug Safety 2000; 9:289-290
HSL6925
Lovdahl U, Riska E.
The construction of gender and mental health in Nordic psychotropic-drug advertising.
Int J Health Serv 2000; 30:(2):387-406
HSL6931
Duncan B, Miller S, Sparks J.
Exposing the mythmakers
Family Therapy Networker 2000; 24:(2):24-33, 52-53
http://web.archive.org/web/20080726120502/http://www.angelfire.com/co2/counseling/drugs-depression.html
HSL6942
Lalonde A.
Selling, or selling out? [response]
Journal of the Society of Obstetricians and Gynaecologists of Canada 2000; 22:(7):497
HSL6951
Bodenheimer T.
Clinical investigators and the pharmaceutical industry (3rd of 3 letters)
New England Journal of Medicine 2000; 343:(7):511
http://content.nejm.org/cgi/content/full/343/7/510
HSL6952
Diamond C.
Is academic medicine for sale? (9th of 13 letters)
New England Journal of Medicine 2000; 343:(7):510
http://content.nejm.org/cgi/content/full/343/7/508
HSL7257
Smith BL, Korn D.
Is there a crisis of accountability in the American research university?
Minerva 2000; 38:(2):129-45
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=Display&DB=pubmed
HSL7848
Soller RW.
OTCs 2000: achievements and challenges
Drug Information Journal 2000; 34:(3):693-701
HSL7849
Morris LA, Pines WL.
Regulation of pharmaceutical promotion in the twenty-first century
Drug Information Journal 2000; 34:(3):861-873
HSL7850
Rosati S.
Community pharmacy and SB393
California Pharmacist 2000; 47:(2):20
HSL7885
Kizer JR, Kimmel SE.
Calcium channel blocker controversy: historical perspective and important lessons for future pharmacotherapies-International Society of Pharmacoepidemiology hot topic
Pharmacoepidemiology and Drug Safety 2000; 9:(1):25-36
HSL7886
Nolan A.
Pharmaceutical advertising in clinical software
Australian Prescriber 2000; 23:(3):52-53, 67
HSL7887
Letendre W, Jackson R.
Marketing your prescription compounding practice. Part 3
International Journal of Pharmaceutical Compounding 2000; 4:(3):199-202
HSL7908
Desselle SP, Aparasu R.
Attitudinal dimensions that determine pharmacists' decisions to support DTCA of prescription medication
Drug Information Journal 2000; 34:(1):103-114
HSL7916
Breu J.
Higher utilization, new products driving prescription spending
Drug Topics 2000; 144:
HSL19379
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, For the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
Meta-analysis of observational studies in epidemiology: a proposal for reporting.
JAMA 2000 19; 283:(15):2008
http://jama.ama-assn.org/content/283/15/2008.long
HSL11552
Mills F.
Patient groups and the Global Pharmaceutical Industry
London: URCH publishing 2000
http://www.amazon.com/Pharmaceutical-Industry-Importance-Directly-Consumer/dp/1859784267/ref=sr_1_1/102-5869202-0212934?ie=UTF8&s=books&qid=1190547090&sr=1-1
HSL13264
Brucks M, Zeithaml VA, Naylor G.
Price and Brand Name As Indicators of Quality Dimensions for Consumer Durables
Journal of the Academy of Marketing Science 2000 Summer; 28:(3):359-374
http://jam.sagepub.com/cgi/content/abstract/28/3/359
HSL13274
Gigerenzer G, Todd PM, and ABC Research Group
Simple Heuristics That Make Us Smart
: Oxford University Press 2000
http://www.oup.com/uk/catalogue/?ci=9780195143812#desc
HSL14746
Liebman M.
Listen Up, Publishers Say - Journal Advertising Sells!
Medical Marketing & Media 2000; 35:(3):89-94
http://www.rxpromoroi.org/add_reading/listenup.html
HSL15823
Rodwin MA, Okamoto E.
Physicians' Conflicts of Interest in Japan and the United States: Lessons for the United States
Journal of Health Politics, Policy and Law 2000; 25:(2):343-376
http://jhppl.dukejournals.org/cgi/content/abstract/25/2/343
HSL19400
Mansfield PR
Year of graduation, level of 'scepticism' and attendance at sponsored meetings are significant predictors of General Practioners' beliefs about the appropriateness of drugs
2000;
http://www.healthyskepticism.org/global/news/int/hsin2010-05
HSL16003
Santos LA.
AGENCIFICAÇÃO, PUBLICIZAÇÃO, CONTRATUALIZAÇÃO E CONTROLE SOCIAL: POSSIBILIDADES NO ÂMBITO DA REFORMA DO
2000
http://diap.ps5.com.br/file/655.pdf
HSL2263
Perri M 3rd, Shinde S, Banavali R.
The past, present, and future of direct-to-consumer prescription drug advertising.
Clin Ther 2001 nov; 21:(10):1798-811
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-3YF46RW-J&_coverDate=10%2F31%2F1999&_alid=305967821&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=18edbefe7a0a00f2fd03cf0fb73399c6
HSL11089
[No authors listed].
Antidepressants and suicide. The history of a controversy--and where it stands today
Harv Ment Health Lett. 2007 July; 24:(1):1-4.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17663067&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL19757
Moynihan R, Cassels A
Selling Sicknes
arena magazine 2005 Dec
HSL16351
Van Duppen D
La guerre des médicaments. Pourquoi sont-ils si chers? Bruxelles: Aden 2005
http://www.chapitre.com/CHAPITRE/fr/BOOK/van-duppen-dirk/la-guerre-des-medicaments-pourquoi-sont-ils-si-chers,1639372.aspx
HSL16352
Welch G
Should I be tested for cancer. Maybe Not and Here’s Why. Berkley and Los Angeles: University of California Press 2004
http://books.google.com.au/books?id=SAXl2PASXNkC&dq=Welch,+Gilbert.+Should+I+be+tested+for+cancer.+Maybe+Not+and+Here’s+Why.&printsec=frontcover&source=bn&hl=en&ei=DrKYSvWeNJODkAWquqyrAg&sa=X&oi=book_result&ct=result&resnum=4#v=onepage&q=&f=false
HSL16353
Young T
Death by Prescription Toronto: Key Porter Books 2009
http://www.amazon.ca/Death-Prescription-Father-Daughters-Killer/dp/1552638251
HSL16381
Moynihan R
Drug Safety: Battle over popular bone drug Fosamax bursts into court
BMJ 2009 08 06;
http://www.bmj.com/cgi/content/extract/339/aug06_1/b3155
HSL16384
Exorcising authors
The Finanical Times 2009 08 30
http://www.ft.com/cms/s/0/f7434ad6-9588-11de-90e0-00144feabdc0.html?nclick_check=1
HSL16393
Bextra Whistleblower Case Started Investigation of Pfizer
Reuters 2009 09 02
http://www.reuters.com/article/pressRelease/idUS158792+02-Sep-2009+PRN20090902
HSL16420
Parsai G
Modify the pill advertisements, Drug Controller asks manufacturers
The Hindu 2009 09 09
http://beta.thehindu.com/news/national/article17177.ece
HSL16454
Williams SJ, Gabe J, Davis P
Pharmaceuticals and Society: Critical Discourses and Debates : Wiley-Blackwell 2009
http://au.wiley.com/WileyCDA/WileyTitle/productCd-1405190841,descCd-description.html
HSL16457
Hutton D
Whistleblowing at Health Canada: Chopra speaks out
CMAJ 2009 09 15; 181:(6-7):
http://www.cmaj.ca/cgi/content/full/181/6-7/E121
HSL16472
PharmaTimes Great Oxford Debate - 2009
Pharma Times 2009
http://www.pharmatimes.com/Competitions/Great-Oxford-Debate/2009debate.aspx
HSL19470
Sladek RM, Phillips PA, Bond MJ.
Measurement properties of the Inventory of Cognitive Bias in Medicine (ICBM).
BMC Med Inform Decis Mak 2008 28; 8:20:
http://www.biomedcentral.com/1472-6947/8/20
HSL16546
Sawaya L
The Persuasion Report Orleans, Canada: Reticulum 2009
https://cp.experthost.com/ssl/18/reticulum.ca/books_s3.php
HSL16587
Issues and Challenges Related to Local Television: Report of the Standing Committee on Canadian Heritage
: House of Commons, Canada 2009 Jun
http://www2.parl.gc.ca/HousePublications/Publication.aspx?DocId=4005108&Language=E&Mode=1&Parl=40&Ses=2
HSL16592
Krimsky S, Sweet E
An Analysis of Toxicology and Medical Journal Conflict-of-Interest Polices
Accountability in Research 2009; 16:(5):235 - 253
http://www.informaworld.com/smpp/content~db=all~content=a914972083
HSL16601
Evaluating evolving sales models & advanced technology for a customer centric approach
Pharmaceutical Sales Force Effectiveness Strategies 2009 Aug
http://www.reportlinker.com/p0148147/Pharmaceutical-Sales-Force-Effectiveness-Strategies-Evaluating-evolving-sales-models--advanced-technology-for-a-customer-centric-approach.html
HSL16644
Drury J, Cocking C, Beale J, Hanson C, Rapley F
The phenomenology of empowerment in collective action
Br J Soc Psychol 2005; 44:(3):309-28
http://eprints.sussex.ac.uk/2063/
HSL16656
Anvisa não pode regulamentar publicidade, diz juiz
Consultor Jurídico 2009 10 23
http://www.conjur.com.br/2009-out-23/anvisa-nao-competencia-regulamentar-publicidade-juiz
HSL16678
Perrone M
GAO: FDA fails to follow up on unproven drugs
Yahoo News 2009 10 26
http://news.yahoo.com/s/ap/20091026/ap_on_he_me/us_fda_unproven_drugs
HSL16679
FDA Needs to Enhance Its Oversight of Drugs Approved on the Basis of Surrogate Endpoints
United States Government Accountability Office 2009 Sep
http://www.gao.gov/new.items/d09866.pdf
HSL16996
Dunn A
Best Strategic Learning Investment in 2010?
Hoenig Carlson E Courtney Justice, The Cournell Group 2009 Dec
http://docs.google.com/fileview?id=0B2pN9F6nMK5MZjQ2MjEyYjMtNzc5Yi00NjVjLWIwZmItYTI1NDZlZTk2NDgw&hl=en
HSL17400
Haag D
rapport in het kader van algemeen toezicht naar aanleiding van het onderzoek bij Sanofi Pasteur MSD naar het geneesmiddel Gardasil (Report about Sanofi)
Staatstoezicht Op De Volksgezondheid 2009 July
http://www.spmsd.nl/143608/Rapport-inspectie-nav-WOB-verzoek.pdf
HSL17401
Haag D
Rapport in het kader van algemeen toezicht naar annleiding van het onderzoek bij GSK naar geneesmiddel Cervarix
Staatstoezicht Op De Volksgezondheid 2009 July
http://www.gsk.nl/downloads/files/rapportonderoekbijGSKnaargeneesmiddelCervarix.pdf
HSL19397
Ching A, Ishihara M
The effects of detailing on prescribing decisions under two-sided learning
Tortonto: University of Toronto 2007
http://mpra.ub.uni-muenchen.de/4935/
HSL19331
Majumdar SR, McAlister FA, Soumerai SB.
Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States.
Am J Med 2003 15; 115:(6):467-72
http://www.ncbi.nlm.nih.gov/pubmed/14567371
HSL19165
Herzberg D.
'Will wonder drugs never cease!': a prehistory of direct-to-consumer advertising.
Pharm Hist 2009; 51:(2):47-56
http://www.ncbi.nlm.nih.gov/pubmed/20853552
HSL19166
Karlowicz KA.
Direct-to-consumer advertising for erectile dysfunction drugs.
Urol Nurs 2009; 29:(4):214
http://www.ncbi.nlm.nih.gov/pubmed/19718935
HSL19167
Stell LK.
Drug reps off campus! Promoting professional purity by suppressing commercial speech.
J Law Med Ethics 2009; 37:(3):431-43,
http://onlinelibrary.wiley.com/doi/10.1111/j.1748-720X.2009.00404.x/abstract
HSL19168
Tamimi NA, Ellis P.
Drug development: from concept to marketing!
Nephron Clin Pract. 2009; 113:(3):c125-31
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=000232592
HSL19382
Canli H, Saatci E, Bozdemir N, Akpinar E, Kiroglu M.
The antibiotic prescribing behaviourof physicians for acute tonsillopharyngitis in primary care.
Ethiop Med J 2006; 44:(2):139-43
http://www.ncbi.nlm.nih.gov/pubmed/17447376
HSL19383
Charbit O
[Influence de la publicité pharmaceutique sur la prescription.] Influence of pharmaceutical advertising on prescription
MD Dissertation Toulouse: University Paul Sabatier Toulouse III. 2003
HSL19384
Freemantle N, Johnson R, Dennis J, Kennedy A, Marchment M
Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice.
Medicines Evaluation Group 2000; 49:(2):174-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014899/?tool=pubmed
HSL19374
Rothman DJ, McDonald WJ, Berkowitz CD, Chimonas SC, DeAngelis CD, Hale RW, Nissen SE, Osborn JE, Scully JH Jr, Thomson GE, Wofsy D.
Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
JAMA 2009 1; 301:(13):1367-72
http://jama.ama-assn.org/content/301/13/1367.long
HSL19652
Henrique Prezzi S
Drotrecogina na Sepse - Contraponto
2007 Aug
http://www.medicinahospitalar.com.br/Aulas/ContrapontoDotrecogina/Drotrecogina_files/intro.htm
HSL19680
Henrique Prezzi S
Drotrecogina na Sepse - Contraponto
Medicina Hospitalar 2007
http://www.medicinahospitalar.com.br/Aulas/ContrapontoDotrecogina/Drotrecogina_files/intro.htm
HSL19722
Jutel A, Menkes DB.
'But doctors do it...': nurses' views of gifts and information from the pharmaceutical industry
Ann Pharmacother. 2009; 43:(6):1057-63
http://www.theannals.com/content/43/6/1057.long
HSL19739
Manchanda P, Wittink Dr, Ching A, Cleanthous P, Ding M, Dong XJ, Leeflang PSH, Misra S, Mizik N, Narayanan S, Steenburgh T, Wieringa JE, Wosinska M, Xie Y,
Understanding Firm, Physician and Consumer Choice Behaviour in the Health Care Industry
Sixth Invitational Choice Symposium hosted by the University of Colorado 2004 Sep
www.springerlink.com/index/518wvx08320847g5.pdf
HSL19743
Pieters T.
About media, audiences and marketing medicines: the interferons.
Clio Med 2002; 66:229-43:
http://www.ncbi.nlm.nih.gov/pubmed/12028679
HSL19744
Jones J
Medical Publishing: Part 3
PMLive.com 2002
HSL19750
Rosenberg CE.
The tyranny of diagnosis: specific entities and individual experience.
Milbank Q 2002; 80:(2):237-60
http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.t01-1-00003/abstract;jsessionid=5B9815EFE8B821B590EAA5D146EE29DB.d01t02?systemMessage=Wiley+Online+Library+will+be+disrupted+14+Jan+from+10-12+GMT+for+monthly+maintenance
HSL19751
Greenhalgh T.
Beware cloth devils.
BMJ 2000 8;
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1127742/?tool=pubmed
HSL19752
Flower R.
Lifestyle drugs: pharmacology and the social agenda.
Trends Pharmacol Sci 2004; 25:(4):182-5
http://www.sciencedirect.com/science/article/pii/S0165614704000549
HSL19755
Lexchin J.
Lifestyle drugs: issues for debate.
CMAJ 2001 15; 164:(10):1449-51
http://www.cmaj.ca/content/164/10/1449.long
HSL19756
Starcevic V.
Opportunistic 'Rediscovery' of mental disorders by the pharmaceutical industry.
Psychother Psychosom 2002; 71:(6):305-10
http://content.karger.com/produktedb/produkte.asp?DOI=65989&typ=pdf
HSL19759
Villanueva P, Peiró S, Librero J, Pereiró I.
Accuracy of pharmaceutical advertisements in medical journals.
Lancet 2003 4; 361:(9351):27-32
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2803%2912118-6/fulltext
HSL19779
Wolfsthal SD, Beasley BW, Kopelman R, Stickley W, Gabryel T, Kahn MJ; Membership Survey and Scientific Data Committee, The Association of Program Directors of Internal Medicine.
Benchmarks of support in internal medicine residency training programs.
Acad Med 2002; 77:(1):50-6
http://pt.wkhealth.com/pt/re/lwwgateway/landingpage.htm;jsessionid=PWVKtY1YDSjYJptRs49jD2dLTnsMb4S3HdnYYvvfJLdw2hQRJG1H!-1165837873!181195629!8091!-1?issn=1040-2446&volume=77&issue=1&spage=50
HSL19811
Durand M
Reality Check: Is It Newsworthy?
Pharma Exec 2003 Apr
pharmexec.findpharma.com/
HSL19832
AMSA move on code
Australian Medicine 2004 May 174
HSL19833
Abraham J.
Transnational industrial power, the medical profession and the regulatory state: adverse drug reactions and the crisis over the safety of Halcion in the Netherlands and the UK.
Soc Sci Med 2002; 55:(9):1671-90
http://linkinghub.elsevier.com/retrieve/pii/S0277953602001600
HSL19847
Taylor B.
Giveaway drugs: good intentions, bad design.
Health Aff (Millwood) 2004; 23:(1):213-7
http://content.healthaffairs.org/content/23/1/213.long
HSL19850
Finaly L
Just Like a Woman
Fashion Date uncertain 200477-78
HSL19854
Pharmaceutical sponsorship of practice newsletters called into question
Medical Forum 2002 Dec10
HSL19873
Mansfield P
Pushing expensive new drugs
Consuming Interest 2001 00 00;
HSL19874
Mansfield P
Pushing expensive new drugs
Consuming Interest 20010
HSL19875
Cassels A
Donuts for doctors: Buying the medical profession
Common Ground 2005 Sep
http://www.commonground.ca/iss/0509170/cg170_donuts.shtml
HSL19876
Cialdini RB
The Science of Persuasion
Scientific American 2001 Feb
http://www.scientificamerican.com/article.cfm?id=the-science-of-persuasion
HSL19889
Josefson D.
Bayer made to tone down aspirin advertisements.
West J Med 2000; 172:(3):154
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1070790/?tool=pubmed
HSL19890
Jaillon P.
The control of prescription drug advertising: a controversial issue.
Clin Pharmacol Ther 2000; 68:(6):583-5
http://www.nature.com/clpt/journal/v68/n6/full/clpt2000137a.html
HSL19898
endurance.
In the heartburn wars: speed vs endurance.
Consum Rep 2004; 69:(3):49
http://www.ncbi.nlm.nih.gov/pubmed/15005092
Page 143 of 144 pages ‹ First < 141 142 143 144 >
